Thursday, 29 June 2017

India News

  • Biocon, Fujifilm launch Insulin Glargine in Japan

    India |  News | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2016

    Singapore: Marking a major achievement in Indian biosimilar history, India's Biocon announced that close on the heels of receiving approval for its IQsulin Glargine from the Japanese regula...Read more

  • India to set up Regional Biotechnology Center

    India |  News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2016

    Singapore: The Indian government recently passed a bill approving the establishment of regional centers for biotechnology in the National Capital Region. Under the auspices of United Nation...Read more

  • Cipla grabs 51 percent stake in Uganda firm for $26 mn

    India |  News | By BioSpectrum Bureau | 0 Comment | 29 Jul, 2015

    Singapore: According to reports, Indian drug giant Cipla has renegotiated payment terms for acquiring majority stake in Uganda's Quality Chemicals. The company announced that it will obtai...Read more

  • Probi ties up with USV to tap India market

    India |  Influencers | By Vipul Murarka | 0 Comment | 03 Jul, 2012

    Swedish Biotechnology research company Probi, which develops probiotics with well-documented beneficial health effects, recently signed a distribution agreement with USV India, a leading In...Read more

  • National Liver Foundation launches Hep B eradication program

    India |  News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2012

    Mumbai: On the occasion of World Hepatitis Day, National Liver Foundation (NLF), an NGO working towards eradication of Hepatitis B pan India, launched its project - Towards Hepatitis B Free...Read more

  • OvPlex to be sold in India from Q3 2012

    India |  News | By BioSpectrum Bureau | 0 Comment | 15 May, 2012

    Mumbai: HealthLinx Limited with distribution partners INEX Innovations Exchange and Metropolis Healthcare will begin selling OvPlex in India beginning the third quarter of 2012. OvPlex will...Read more

  • Cipla to build biotech facility in South Africa

    India |  News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2016

    Singapore: Indian drug major Cipla, recently announced that its South African subsidiary will invest R1.3 billion into the country's first biotech manufacturing facility, for the production...Read more

  • Dr Appaji: Pharmexcil is taking Indian Pharma to new heights

    India |  Influencers | By Vipul Murarka | 0 Comment | 02 Nov, 2012

    The Pharmaceutical Export Promotion Council of India (PHARMEXCIL), set up by the Ministry of Commerce and Industry, Government of India, has been tasked with the promotion of the Indian pha...Read more

  • Hetreo launches biosimilar for colorectal cancer

    India |  News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2016

    Singapore: Indian drug major Hetero recently announced the launch of biosimilar of 'Bevacizumab', used in treating metastatic colorectal cancer (mCRC), under the brand name 'CizumabTM'. Hyd...Read more

  • Cipla keeps the flag high for affordable drugs

    India |  Analysis | By Amrita Tejasvi | 0 Comment | 04 Jun, 2013

    Cipla, which is known for providing affordable drugs to cancer and HIV patients in developing countries, clocked a growth of 17 percent in the year ending 2012. The domestic turnover incr...Read more

  • Phenomenex extends Lux Chiral Bulk Media Line

    India |  News | By BioSpectrum Bureau | 0 Comment | 28 Jun, 2014

    Singapore:A global leader in advanced technologies for separation sciences, Phenomenex has announced the extension of its successful Lux chiral bulk media line to meet the needs of preparat...Read more

  • Activists challenge Gilead to give up Hep C drug patent

    India |  News | By BioSpectrum Bureau | 0 Comment | 21 May, 2015

    Singapore: Initiative for Medicines, Access & Knowledge (I-MAK), a team of lawyers and scientists campaigning for global accessibility of medicines for hepatitis C and HIV patients, has...Read more

  • Teva, Sun to pay $2.15 bn to Pfizer, Takeda to settle patent suit

    India |  News | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2013

    Singapore: Teva Pharmaceuticals Industries, Israel, and Sun Pharmaceutical Industries, India, are going to pay a combined amount of $2.15 billion to US-based Pfizer in order to settle a pat...Read more

  • Adcock-Ingram buys Cosme Farma India for $86 mn

    India |  News | By BioSpectrum Bureau | 0 Comment | 16 Jul, 2012

    Singapore: Adcock-Ingram, which is one of the biggest pharma companies of South Africa, paid a huge premium to buy out Indian firm, Cosme Farma, in an attempt to gain more access to markets...Read more

  • Samantha Su, Simranjit Singh: Finding skilled professionals is a challenge in Singapore

    India |  Opinion | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013

    In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Theoretically, the synergy created between them spurs the company to bu...Read more

  • Venus bags additional US patent for Vancoplus

    India |  Regulatory | By BioSpectrum Bureau | 0 Comment | 29 May, 2014

    Singapore: India's Chandigarh based Venus Remedies has bagged an additional patent for Vancoplus from USPTO. Vancoplus is an antibiotic adjuvant entity, effective against the deadly resista...Read more

  • Aortic stent grafts market to grow at slow pace'

    India |  Analysis | By BioSpectrum Bureau | 0 Comment | 17 Oct, 2014

    Singapore: The global aortic stent grafts market will increase in value from an estimated $1.2 billion in 2013 to just over $1.9 billion by 2020, representing a compound annual growth rate ...Read more

  • Ghana to probe import of Indian anti-malarial drug

    India |  News | By BioSpectrum Bureau | 0 Comment | 24 Oct, 2013

    Singapore: Ghana's Health Ministry has set up a three-member Ministerial Committee to investigate the import of an anti-malarial medicine for children from India. The Country's Food and Dr...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls